MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
3129.67%
Quick Ratio
3125.43%
Cash Ratio
95.70%
Debt to Asset Ratio
3.83%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
33,700 32,490 45,145 14,624
Marketable securities
1,042,542 709,665 635,118 646,428
Inventory
1,493 1,565 1,501 NaN
Accounts receivable, net
1,275 688 515 NaN
Accounts receivable - other
NaN NaN NaN 562
Prepaid expenses and other current assets
23,133 15,067 13,511 11,416
Total current assets
1,102,143 759,475 695,790 673,030
Total property and equipment, cost
17,368 17,070 15,952 NaN
Less accumulated depreciation
2,294 1,474 623 NaN
Property and equipment, net
15,074 15,596 15,329 253
Operating lease right-of-use assets
4,512 3,971 4,203 965
Gross carrying amount
NaN NaN 1,700 NaN
Accumulated amortization
NaN NaN 28 NaN
Intangible assets, net
560 575 1,672 NaN
Goodwill
10,297 10,297 12,805 NaN
Note receivable, net
NaN NaN NaN 26,675
Other assets
2,676 1,678 114 522
Total assets
1,135,262 791,592 729,913 701,445
Accounts payable
8,236 5,714 9,193 7,125
Operating lease liabilities, current portion
1,066 915 912 288
Accrued expenses and other current liabilities
25,914 24,207 20,423 22,968
Total current liabilities
35,216 30,836 30,528 30,381
Long-term debt
3,000 3,000 3,000 NaN
Operating lease liabilities, net of current portion
3,509 3,106 3,329 706
Deferred tax liability
307 307 1,609 NaN
Other liabilities
1,451 1,741 3,804 NaN
Total liabilities
43,483 38,990 42,270 31,087
Common stock, 0.0001 par value per share 700,000,000 and 700,000,000 share authorized as of march 31, 2026 and december 31, 2025, respectively 88,007,761 and 80,689,128 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
9 8 8 8
Additional paid-in capital
1,530,948 1,131,570 1,025,302 964,209
Accumulated deficit
-439,178 -378,976 -337,667 -293,859
Total stockholders' equity
1,091,779 752,602 687,643 670,358
Total liabilities and stockholders' equity
1,135,262 791,592 729,913 701,445
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$1,042,542K Cash and cashequivalents$33,700K Prepaid expenses andother current assets$23,133K Inventory$1,493K Accounts receivable, net$1,275K Total property andequipment, cost$17,368K Total current assets$1,102,143K Property and equipment,net$15,074K Goodwill$10,297K Operating leaseright-of-use assets$4,512K Other assets$2,676K Intangible assets, net$560K Less accumulateddepreciation$2,294K Total assets$1,135,262K Total liabilities andstockholders' equity$1,135,262K Total stockholders'equity$1,091,779K Total liabilities$43,483K Accumulated deficit-$439,178K Additional paid-in capital$1,530,948K Total currentliabilities$35,216K Operating leaseliabilities, net of current...$3,509K Long-term debt$3,000K Other liabilities$1,451K Deferred tax liability$307K Common stock, 0.0001par value per share...$9K Accrued expenses andother current...$25,914K Accounts payable$8,236K Operating leaseliabilities, current portion$1,066K

CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON)